Tabula Rasa HealthCare Stock Price, News & Analysis (NASDAQ:TRHC) $10.50 +0.09 (+0.86%) (As of 11/3/2023) Add Compare Share Share Today's Range$10.41▼$10.5050-Day Range$10.30▼$10.5052-Week Range$3.15▼$10.50Volume1.31 million shsAverage Volume225,500 shsMarket Capitalization$284.13 millionP/E RatioN/ADividend YieldN/APrice Target$8.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Tabula Rasa HealthCare MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside23.8% Downside$8.00 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.54) to ($0.35) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.11 out of 5 starsMedical Sector932nd out of 951 stocksHealth Information Services Industry5th out of 5 stocks 1.3 Analyst's Opinion Consensus RatingTabula Rasa HealthCare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $8.00, Tabula Rasa HealthCare has a forecasted downside of 23.8% from its current price of $10.50.Amount of Analyst CoverageTabula Rasa HealthCare has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for TRHC. Previous Next 0.0 Dividend Strength Dividend YieldTabula Rasa HealthCare does not currently pay a dividend.Dividend GrowthTabula Rasa HealthCare does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TRHC. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Tabula Rasa HealthCare this week, compared to 1 article on an average week.Search Interest1 people have searched for TRHC on MarketBeat in the last 30 days. MarketBeat FollowsOnly 4 people have added Tabula Rasa HealthCare to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Tabula Rasa HealthCare insiders have not sold or bought any company stock.Percentage Held by Insiders30.30% of the stock of Tabula Rasa HealthCare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions61.88% of the stock of Tabula Rasa HealthCare is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Tabula Rasa HealthCare are expected to grow in the coming year, from ($0.54) to ($0.35) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Tabula Rasa HealthCare is -2.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Tabula Rasa HealthCare is -2.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About Tabula Rasa HealthCare Stock (NASDAQ:TRHC)Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise Risk Score, a medication risk stratification technology for identification of patients in need of clinical intervention. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third-party administrator services. As of December 31, 2022, it served approximately 150 healthcare organizations. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey. As of November 3, 2023, Tabula Rasa HealthCare, Inc. operates as a subsidiary of Exact Care Pharmacy, LLC.Read More TRHC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TRHC Stock News HeadlinesNovember 29, 2023 | americanbankingnews.comTabula Rasa HealthCare (NASDAQ:TRHC) Now Covered by StockNews.comNovember 22, 2023 | americanbankingnews.comTabula Rasa HealthCare (NASDAQ:TRHC) & Forian (NASDAQ:FORA) Critical ContrastDecember 2, 2023 | DTI Trader (Ad)All the trading advice you’ve ever received boils down to thisAll the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.October 31, 2023 | msn.comTabula Rasa HealthCare gets stockholder nod for going-private transactionOctober 31, 2023 | finance.yahoo.comTabula Rasa HealthCare Stockholders Approve Acquisition by Nautic PartnersSeptember 20, 2023 | finance.yahoo.comWith 46% ownership, Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) has piqued the interest of institutional investorsSeptember 6, 2023 | thestreet.comTabula Rasa HealthCare Inc. NewsAugust 31, 2023 | msn.comTabula Rasa HealthCare (TRHC) Price Target Increased by 23.38% to 10.54December 2, 2023 | DTI Trader (Ad)All the trading advice you’ve ever received boils down to thisAll the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.August 8, 2023 | markets.businessinsider.comStifel Nicolaus Sticks to Their Hold Rating for Tabula Rasa HealthCare (TRHC)August 8, 2023 | msn.comWilliam Blair Downgrades Tabula Rasa HealthCare (TRHC)August 8, 2023 | markets.businessinsider.comPiper Sandler Reaffirms Their Hold Rating on Tabula Rasa HealthCare (TRHC)August 8, 2023 | markets.businessinsider.comWhy Are Tabula Rasa HealthCare Shares Moving Higher Today?August 8, 2023 | finance.yahoo.comTabula Rasa Healthcare (TRHC) Q2 Earnings and Revenues Surpass EstimatesAugust 8, 2023 | finance.yahoo.comCompared to Estimates, Tabula Rasa Healthcare (TRHC) Q2 Earnings: A Look at Key MetricsAugust 8, 2023 | finance.yahoo.comTabula Rasa agrees to be acquired in $570M all-cash deal, less than a year after pushing out its founderAugust 8, 2023 | finance.yahoo.comWhy Shares of Tabula Rasa HealthCare Are Soaring MondayAugust 7, 2023 | finanznachrichten.deTabula Rasa HealthCare, Inc.: Tabula Rasa HealthCare Reports Second Quarter 2023 Financial ResultsAugust 7, 2023 | seekingalpha.comTabula Rasa going private; will merge with ExactCare PharmacyAugust 7, 2023 | marketwatch.comTabula Rasa Shares Rally Premarket on Private-Equity BuyoutAugust 7, 2023 | markets.businessinsider.comTabula Rasa To Go Private In $570 Mln Deal With Nautic Partners; Stock Up In PremarketAugust 7, 2023 | marketwatch.comNautic Partners to Buy Tabula Rasa HealthCare in $570 Million Deal >TRHCAugust 7, 2023 | finance.yahoo.comTabula Rasa and ExactCare to Combine to Create a Leading, Independent Pharmacy Care Management Company That Services Patients with the Most Complex NeedsAugust 7, 2023 | finance.yahoo.comTabula Rasa HealthCare Reports Second Quarter 2023 Financial ResultsAugust 4, 2023 | benzinga.comEarnings Outlook For Tabula Rasa HealthCareJuly 25, 2023 | finance.yahoo.comTabula Rasa HealthCare Schedules Second Quarter 2023 Earnings Conference CallJune 12, 2023 | finance.yahoo.comTabula Rasa Healthcare (TRHC) Surges 7.8%: Is This an Indication of Further Gains?See More Headlines Receive TRHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tabula Rasa HealthCare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/04/2021Today12/02/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Health Information Services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TRHC CUSIPN/A CIK1651561 Webwww.tabularasahealthcare.com Phone(866) 648-2767FaxN/AEmployees1,027Year FoundedN/APrice Target and Rating Average Stock Price Target$8.00 High Stock Price Target$10.00 Low Stock Price Target$6.00 Potential Upside/Downside-23.8%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($3.85) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-147,510,000.00 Net Margins-28.23% Pretax Margin-17.99% Return on EquityN/A Return on Assets-8.80% Debt Debt-to-Equity RatioN/A Current Ratio1.57 Quick Ratio1.47 Sales & Book Value Annual Sales$299.52 million Price / Sales0.95 Cash FlowN/A Price / Cash FlowN/A Book Value($2.10) per share Price / Book-5.00Miscellaneous Outstanding Shares27,060,000Free Float18,857,000Market Cap$284.13 million OptionableOptionable Beta1.57 The Best High-Yield Dividend Stocks for 2023Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Brian W. Adams (Age 41)CEO, President & Director Comp: $668.21kMr. Thomas J. Cancro C.F.A. (Age 55)CPA, Chief Financial Officer Comp: $523.42kMr. Michael Greenhalgh BScPharm (Age 61)RPh, COO & President of Pharmacy Services Comp: $630.9kMr. Michael Bruno (Age 35)VP, Corporate Controller & Chief Accounting Officer Mr. Bob Sullivan M.S.Chief Technology OfficerMr. Phillip W. Heath MS (Age 57)Chief Administrative Officer Mr. Frank Sparacino C.F.A.CPA, Senior Vice President of Investor Relations & Corporate DevelopmentMr. Richard W. Rew II (Age 55)Chief Legal Officer & Corporate Secretary Ms. Kathleen D Larkin M.B.A.Chief People OfficerMs. Andrea Carolan Speers M.S. (Age 42)Chief of Staff More ExecutivesKey CompetitorsAugmedixNASDAQ:AUGXNutex HealthNASDAQ:NUTXForianNASDAQ:FORAFulcrum TherapeuticsNASDAQ:FULCNurix TherapeuticsNASDAQ:NRIXView All CompetitorsInsiders & InstitutionsGraham Capital Management L.P.Bought 11,088 shares on 11/22/2023Ownership: 0.041%Jacobs Levy Equity Management Inc.Sold 40,460 shares on 11/17/2023Ownership: 0.267%Kennedy Capital Management LLCSold 60,472 shares on 11/15/2023Ownership: 1.112%EHP Funds Inc.Bought 225,000 shares on 11/15/2023Ownership: 0.831%OMERS ADMINISTRATION CorpBought 36,300 shares on 11/14/2023Ownership: 0.134%View All Insider TransactionsView All Institutional Transactions TRHC Stock Analysis - Frequently Asked Questions Should I buy or sell Tabula Rasa HealthCare stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TRHC shares. View TRHC analyst ratings or view top-rated stocks. What is Tabula Rasa HealthCare's stock price target for 2024? 4 Wall Street research analysts have issued 12 month price targets for Tabula Rasa HealthCare's stock. Their TRHC share price targets range from $6.00 to $10.00. On average, they predict the company's share price to reach $8.00 in the next twelve months. This suggests that the stock has a possible downside of 23.8%. View analysts price targets for TRHC or view top-rated stocks among Wall Street analysts. How have TRHC shares performed in 2023? Tabula Rasa HealthCare's stock was trading at $4.95 at the start of the year. Since then, TRHC stock has increased by 112.1% and is now trading at $10.50. View the best growth stocks for 2023 here. How were Tabula Rasa HealthCare's earnings last quarter? Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) issued its earnings results on Thursday, November, 4th. The company reported ($0.04) EPS for the quarter, beating analysts' consensus estimates of ($0.19) by $0.15. The company earned $86.60 million during the quarter, compared to analyst estimates of $88.54 million. The company's quarterly revenue was up 22.8% on a year-over-year basis. During the same period in the previous year, the business earned ($0.35) earnings per share. What is Calvin H. Knowlton, BScPharm, MDiv, PhD's approval rating as Tabula Rasa HealthCare's CEO? 24 employees have rated Tabula Rasa HealthCare Chief Executive Officer Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com. Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among the company's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Tabula Rasa HealthCare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), Boeing (BA), Salesforce (CRM), Intel (INTC) and Netflix (NFLX). When did Tabula Rasa HealthCare IPO? (TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers. Who are Tabula Rasa HealthCare's major shareholders? Tabula Rasa HealthCare's stock is owned by a number of retail and institutional investors. Top institutional investors include Beryl Capital Management LLC (2.19%), Qube Research & Technologies Ltd (1.36%), Gabelli Funds LLC (1.31%), Kennedy Capital Management LLC (1.11%), GABELLI & Co INVESTMENT ADVISERS INC. (0.91%) and EHP Funds Inc. (0.83%). Insiders that own company stock include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Indaba Capital Management, LP, Jan Berger, Michael Greenhalgh, Michael J Purcell, Orsula V Knowlton, Orsula V Knowlton, Samira Beckwith and Thomas Cancro. View institutional ownership trends. How do I buy shares of Tabula Rasa HealthCare? Shares of TRHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:TRHC) was last updated on 12/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tabula Rasa HealthCare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.